• Info
  • Home
  • About
  • Review Guidelines
  • Subscribe to Alerts
  • Search
  • Article Type

    Publication Date

  • Author Info
  • Why Submit?
  • Fees
  • Article Types
  • Author Guidelines
  • Submission Checklist
  • Contact Editorial Office
  • Submit Manuscript
Start date should be earlier than end date. OK Please enter the date in dd/mm/yyyy format or use the calendar icon to the left of the date field.

About

Facts

Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, PsycINFO

PMCID: all published articles receive a PMCID

Mission Statement

Psychopharmacology is a specialty section of Frontiers in Pharmacology and Frontiers in Psychiatry.

The section published major insights into animal and human psychopharmacology, as well as the neurobiological basis of behavior induces by psychotropics. We welcome papers concerned with the interplay between behavior and neurobiological analysis at all levels using psychotropics as tools including molecular biology, genetics, and morphological, biochemical, neurochemical, electrophysiological, neuroendocrinal and neuroimaging studies. While Psychopharmacology is primarily centered on animal behavior, human studies that can validate conclusions from animal research are also welcome. Work in all animal species, including humans, is welcome, and integrative and translational approaches combining animal and human research are encouraged. In recent years, translational work has proven to be particularly suitable to address topics and questions related to psychopathology, with outstanding examples showing how animal studies can help identify key genetic mechanisms of behavioral deviation in humans and, conversely, how innovative findings in humans are directing essential work in animals. Our ultimate goal is to accelerate the progress in this research area at a critical time when we are facing multiple challenges: from the need to integrate findings obtained at different levels of analysis to the constant redefinition of topics and approaches that concern and characterize the field of psychopharmacology.

Psychopharmacology welcomes submissions of the following tier 1 articles: Book Review, Clinical Case Study, Clinical Trial, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge and Technology Report.

All manuscripts must be submitted directly to the section Psychopharmacology, where they are peer reviewed by the associate and review editors of the specialty section.

Articles published in the section Psychopharmacology will be subject to the Frontiers evaluation system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a prestigious Frontiers Focused Review - a tier 2 article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Pharmacology and Psychiatry.

Open Access Statement

Frontiers’ philosophy is that all research is for the benefit of humankind. Research is the product of an investment by society and therefore its fruits should be returned to all people without borders or discrimination, serving society universally and in a transparent fashion.

That is why Frontiers provides online free and open access to all of its research publications. For more information on open access click here.

Copyright Statement

Under the Frontiers Conditions for Website Use and the Frontiers General Conditions for Authors, authors of articles published in Frontiers journals retain copyright on their articles, except for any third-party images and other materials added by Frontiers, which are subject to copyright of their respective owners. Authors are therefore free to disseminate and re-publish their articles, subject to any requirements of third-party copyright owners and subject to the original publication being fully cited. Visitors may also download and forward articles subject to the citation requirements and subject to any fees Frontiers may charge for downloading licenses. The ability to copy, download, forward or otherwise distribute any materials is always subject to any copyright notices displayed. Copyright notices must be displayed prominently and may not be obliterated, deleted or hidden, totally or partially. A charge may be made for some facilities (such as downloading of e-magazines), where stated.

Quality

Each Frontiers article is a landmark of the highest quality, thanks to genuinely collaborative interactions between authors and review editors, who include some of the world's best academicians. Frontiers is well aware of the potential impact of published research both on future research and on society and, hence, does not support superficial review, light review or no-review publishing models. Research must be certified by peers before entering a stream of knowledge that may eventually reach the public - and shape society. Therefore, Frontiers only applies the most rigorous and unbiased reviews, established in the high standards of the Frontiers Review System. Furthermore, only the top certified research, evaluated through the democratic Frontiers Evaluation System, is disseminated to increasingly wider communities as it gradually climbs the tiers of the Frontiers Tiering System from specialized expert readership towards public understanding.

Contact


Frontiers Editorial Office

EPFL - Innovation Square, Building I
CH – 1015 Lausanne
Switzerland

Tel +41(0)21 510 17 11
Fax +41 (0)21 510 17 01

psychiatry.editorial.office@frontiersin.org

Frontiers Support

Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01

support@frontiersin.org

© 2007 - 2014 Frontiers Media S.A. All Rights Reserved